STOCKHOLDERS’ EQUITY | NOTE 9 – STOCKHOLDERS’ EQUITY The Company’s equity at September 30, 2021 consisted of 75,000,000 2,000,000 0.001 31,364,327 23,230,654 28,000 1,000 On August 26, 2020, the Company’s shareholders of record approved the increase of the Company’s authorized common stock, par value $ 0.001 75,000,000 100,000,000 150,000,000 The Company has reserved a total of 3,000,000 2,700,000 1,000,000 1,700,000 On February 11, 2019, the Company’s Board of Directors approved a 2019 Equity Incentive Plan (the “2019 Plan”). In order for the 2019 Plan to grant “qualified stock options” to employees, it required approval by the Corporation’s shareholders within 12 months from the date of the 2019 Plan. The 2019 Plan was never approved by the shareholders. Therefore, any options granted under the 2019 Plan prior to shareholder approval will be “non-qualified”. Pursuant to the 2019 Plan, the Company has reserved a total of 3,000,000 1,200,000 Common Stock Issued for Services During the nine months ended September 31, 2021, the Company committed to issue 200,000 280,000 During the nine months ended September 30, 2021, the Company issued 50,000 66,000 During the nine months ended September 30, 2021, the Company issued an aggregate of 100,000 132,000 During the nine months ended September 30, 2021, the Company issued 45,946 61,108 Common Stock Issued for Cash On February 22, 2021, the Company received cash of $ 45,000 100,000 On May 7, 2021, the Company received cash of $ 20,000 40,000 Common Stock Issued from warrants and options exercise. During the nine months ended September 30, 2021, the Company issued 160,000 50,000 During the nine months ended September 30, 2021, the Company issued 1,000,000 50,000 Common Stock sold with a Promise to Deliver Title to Plot of Land and Warrants On December 8, 2020, the Company received cash proceeds of $ 20,000 50,000 20,000 11,890 8,110 On December 31, 2020, the Company received cash proceeds of $ 30,000 50,000 30,000 20,622 9,378 On April 22, 2021, the Company received cash proceeds of $ 35,000 70,000 35,000 29,521 5,479 Common Stock Issued for debt settlement. On December 31, 2020, the Company executed amendments to promissory notes with six (6) existing investors to extend the maturity date for the issuance of an aggregate of 23,000 10,000 On January 1, 2021, the Company issued an aggregate of 95,000 75,600 On January 1, 2021, the Company issued an aggregate of 23,000 8,970 On February 25, 2021, the Company issued 85,000 130,900 On July 1, 2021, the Company issued an aggregate of 35,000 12,605 All shares of common stock issued during the three and nine months ended September 30, 2021, were unregistered. Common Stock Issued for equity-method investment. On May 14, 2021, the Company issued 3,000,000 2,580,000 25 Common Stock issued following registered offering (July 2021 offering) On July 26, 2021, the Company entered into securities purchase agreements with certain institutional and accredited investors for the issuance and sale of 3,000,000 0.68 0.68 2,040,000 1,800,000 Preferred Stock On November 6, 2019, the Company authorized and issued 1,000 350,000 500,000 293,500 Warrants A summary of the Company’s warrant activity during the nine months ended September 30, 2021, is presented below: SCHEDULE OF WARRANTS ACTIVITY Weighted Weighted Contract Number of Warrants Average Exercise Price Term (Year) Outstanding at December 31, 2020 460,000 $ 0.38 0.70 Granted 3,180,000 0.69 5.33 Exercised (160,000 ) 0.31 0.25 Forfeited-Canceled (150,000 ) 0.33 - Outstanding at September 30, 2021 3,330,000 $ 0.68 5.11 Exercisable at September 30, 2021 3,300,000 During the nine months ended September 30, 2021, the Company issued 3,000,000 3,000,000 0.68 0.68 The placement agent was granted 180,000 0.85 The aggregate intrinsic value as of September 30, 2021, and December 31, 2020, was approximately $ 63,000 4,600 Options A summary of the Company’s option activity during the nine months ended September 30, 2021, is presented below: SCHEDULE OF OPTION ACTIVITY Weighted Weighted Contract Number of Options Average Exercise Price Term (Year) Outstanding at December 31, 2020 2,900,000 $ 0.43 3.35 Granted 1,000,000 0.05 1.00 Exercised (1,000,000 ) (0.05 ) ( 1.00 ) Forfeited-Canceled - - - Outstanding at September 30, 2021 2,900,000 $ 0.43 2.60 Exercisable at September 30, 2021 1,568,750 Options outstanding as of September 30, 2021, and December 31, 2020, had aggregate intrinsic value of $ 889,000 158,000 0.35 0.3 |